Literature DB >> 27487748

Inherited dysfunctional platelet P2Y12 receptor mutations associated with bleeding disorders.

Anna Lecchi, Eti A Femia, Silvia Paoletta, Arnaud Dupuis, Philippe Ohlmann, Christian Gachet, Kenneth A Jacobson, Katharina Machura1, Gian M Podda, Barbara Zieger, Marco Cattaneo.   

Abstract

The platelet adenosine 5'-diphosphate (ADP) receptor P2Y12 (P2Y12R) plays a critical role in platelet aggregation. The present report illustrates an update of dysfunctional platelet P2Y12R mutations diagnosed with congenital lifelong bleeding problems. Described patients with heterozygous or homozygous substitution in the P2Y12R gene and qualitative abnormalities of the platelet P2Y12R are summarized. Recently, a further dysfunctional variant of P2Y12R has been identified in two brothers who presented with a lifelong severe bleeding disorder. During in vitro aggregation studies, the patient´s platelets show a markedly reduced and rapid reversible ADP-promoted aggregation. A homozygous c.561T>A substitution that changes the codon for His187 to Gln (p.His187Gln) in the P2Y12R gene has been identified. This mutation causes no change in receptor expression but decreases the affinity of the ligand for the receptor, even at high concentrations. Structure modelling studies indicated that the p.His187Gln mutation, located in the fifth transmembrane spanning domain (TM5), impairs conformational changes of the receptor. Structural integrity of the TM5 region is necessary for agonist and antagonist binding and for correct receptor function.

Entities:  

Keywords:  P2Y12 receptor; Platelets; mutation

Mesh:

Substances:

Year:  2016        PMID: 27487748      PMCID: PMC5099093          DOI: 10.5482/HAMO-16-03-0010

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


  31 in total

Review 1.  New P2Y(12) inhibitors.

Authors:  Marco Cattaneo
Journal:  Circulation       Date:  2010-01-05       Impact factor: 29.690

2.  Structure of the human P2Y12 receptor in complex with an antithrombotic drug.

Authors:  Kaihua Zhang; Jin Zhang; Zhan-Guo Gao; Dandan Zhang; Lan Zhu; Gye Won Han; Steven M Moss; Silvia Paoletta; Evgeny Kiselev; Weizhen Lu; Gustavo Fenalti; Wenru Zhang; Christa E Müller; Huaiyu Yang; Hualiang Jiang; Vadim Cherezov; Vsevolod Katritch; Kenneth A Jacobson; Raymond C Stevens; Beili Wu; Qiang Zhao
Journal:  Nature       Date:  2014-03-23       Impact factor: 49.962

3.  Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.

Authors:  C J Foster; D M Prosser; J M Agans; Y Zhai; M D Smith; J E Lachowicz; F L Zhang; E Gustafson; F J Monsma; M T Wiekowski; S J Abbondanzo; D N Cook; M L Bayne; S A Lira; M S Chintala
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.

Authors:  J E Fabre; M Nguyen; A Latour; J A Keifer; L P Audoly; T M Coffman; B H Koller
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

5.  The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB-0413.

Authors:  Philippe Ohlmann; Anna Lecchi; Ali El-Tayeb; Christa E Müller; Marco Cattaneo; Christian Gachet
Journal:  Purinergic Signal       Date:  2012-08-15       Impact factor: 3.765

Review 6.  ADP receptors of platelets and their inhibition.

Authors:  C Gachet
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

Review 7.  The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects.

Authors:  Marco Cattaneo
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

8.  An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.

Authors:  P Nurden; P Savi; E Heilmann; C Bihour; J M Herbert; J P Maffrand; A Nurden
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow.

Authors:  B Savage; F Almus-Jacobs; Z M Ruggeri
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

10.  A novel mutation in the P2Y12 receptor and a function-reducing polymorphism in protease-activated receptor 1 in a patient with chronic bleeding.

Authors:  Y M Patel; M Lordkipanidzé; G C Lowe; S P Nisar; K Garner; J Stockley; M E Daly; M Mitchell; S P Watson; S K Austin; S J Mundell
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

View more
  4 in total

Review 1.  The Function and Regulation of Platelet P2Y12 Receptor.

Authors:  Xiaohua Li; Guoxing Zhang; Xia Cao
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-28       Impact factor: 3.727

2.  Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel.

Authors:  Satoshi Niijima; Tsukasa Ohmori; Kazuomi Kario
Journal:  Thromb J       Date:  2018-03-15

Review 3.  Ticagrelor - toward more efficient platelet inhibition and beyond.

Authors:  Michał J Kubisa; Mateusz P Jezewski; Aleksandra Gasecka; Jolanta M Siller-Matula; Marek Postuła
Journal:  Ther Clin Risk Manag       Date:  2018-01-17       Impact factor: 2.423

Review 4.  Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy.

Authors:  Paquita Nurden; Simon Stritt; Remi Favier; Alan T Nurden
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.